重症监护室代理决策者四支持干预的随机临床试验
该研究在宾夕法尼亚州一个医疗系统的6个ICU开展患者水平随机临床试验,纳入291例死亡或严重长期功能损害高风险的无行为能力重症患者的444名代理决策者(干预组233名,对照组211名)。干预由外部干预者每日与代理决策者互动,提供 emotional support、communication support、decisional support 及必要时 anticipatory grief support 四类方案化支持;对照组接受常规护理加两次简短重症教育。主要终点为6个月时代理决策者医院焦虑抑郁量表总分(范围0-42),结果显示无干预效应(β=0.06;95%CI -0.07至0.19;P=0.35),预设次要终点亦无效应。结论认为该家庭支持干预未减轻代理决策者长期心理症状负担。
要点
- 在6个ICU中,由外部干预者提供的四支持干预未降低代理决策者6个月时医院焦虑抑郁量表总分(β=0.06;95%CI -0.07至0.19;P=0.35)。
- 干预实施保真度高:关键干预要素按方案执行频率97.1%,干预实施质量评分2.9±0.2(量表1-3分,分数越高表示质量越高)。
- 共纳入444名代理决策者(干预组233名,对照组211名),对应291例患者。
- 预设次要终点同样未显示干预效应。
- 对于死亡或严重长期功能损害高风险的无行为能力重症患者,该干预未减轻代理决策者长期心理症状负担。
适用人群与场景
- 在宾夕法尼亚州一个医疗系统的6个ICU中,纳入死亡或严重长期功能损害高风险的无行为能力重症患者的代理决策者。
处置流程与药物剂量
- 干预由外部干预者每日与代理决策者互动,提供四类方案化支持:情感支持、沟通支持、决策支持,以及必要时 anticipatory grief support(预期性悲伤支持)。
- 对照组接受常规护理加两次关于重症的简短教育课程。
研究设计与关键结果
- 研究类型为患者水平随机临床试验,在6个ICU开展,共纳入291例患者的444名代理决策者(干预组233名,对照组211名)。
- 主要终点为代理决策者6个月时医院焦虑抑郁量表总分(范围0-42),结果显示无干预效应(β=0.06;95%CI -0.07至0.19;P=0.35)。
- 干预实施保真度高:关键干预要素按方案执行频率97.1%;干预实施质量评分2.9±0.2(量表1-3分,分数越高表示质量越高)。
- 预设次要终点同样未显示干预效应。
证据类型、等级与局限
- 证据类型:随机临床试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对于死亡或严重长期功能损害高风险的无行为能力重症患者,由外部干预者提供的四支持家庭支持干预未降低代理决策者6个月时医院焦虑抑郁量表总分,预设次要终点亦无效应。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Individuals acting as surrogate decision-makers for critically ill patients frequently struggle in this role and experience high levels of long-term psychological distress. Prior interventions that were designed solely to improve information sharing between clinicians and family members have been ineffective. Objectives: We sought to examine the impact of a multicomponent family support intervention on patient and family outcomes. Methods: We conducted a patient-level randomized clinical trial at six ICUs in a healthcare system in Pennsylvania. An external interventionist interacted daily with surrogate decision-makers for incapacitated, critically ill patients at high risk of death or severe long-term functional impairment to deliver four types of protocolized support during the ICU stay: emotional support; communication support; decisional support; and, if indicated, anticipatory grief support. The control condition involved usual care plus two brief education sessions about critical illness. Measurements and Main Results: Primary outcome was the surrogates' scores on the Hospital Anxiety and Depression Scale at 6 months (range = 0-42). A total of 444 surrogates of 291 patients were enrolled (233 surrogates in intervention and 211 in control). The Four Supports intervention was delivered with high fidelity (frequency of per protocol delivery of key intervention elements, 97.1%; quality rating of intervention delivery, 2.9 ± 0.2 on a scale ranging from 1 to 3, with higher scores indicating higher quality of intervention delivery). There was no intervention effect on the primary outcome, surrogates' Hospital Anxiety and Depression Scale total scores at 6-month follow-up (β = 0.06; 95% confidence interval, -0.07 to 0.19; P = 0.35), or the prespecified secondary outcomes. Conclusions: Among critically ill patients at high risk of death or functional impairment, a family support intervention delivered by an external interventionist did not reduce surrogates' long-term psychological symptom burden.Clinical trial registered with www.clinicaltrials.gov (NCT01982877).
参考来源
- Butler RA, Seaman JB, Felman K, et al. Randomized Clinical Trial of the Four Supports Intervention for Surrogate Decision-Makers in Intensive Care Units. Am J Respir Crit Care Med. 2025. PMID: 39586017. doi:10.1164/rccm.202405-0931OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。